ST Jingfeng
SZSE · 000908
Market Cap$12.6B
Revenue$385.5M
P/E Ratio24.7
Listed OnSZSE
Ticker000908
IndustryDrug Manufacturers - General
CEO / ExecMs. Li Zhang
HeadquartersChangde
MarketMainland China
Websitewww.jfzhiyao.com
Overview
CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the fields of cardiovascular disease, orthopedic pain disease, tumor disease, women and children. Th
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.